Nobel Biocare (NVST) Narxning foydaga nisbati

Envista Holdings Corp - NVST emitenti grafik logotipi

Envista Holdings kuchli muhandislik poydevoriga asoslangan barqaror kredit profilini saqlab qolmoqda. Emitentning P/E koeffitsiyenti barqaror dinamikani namoyish etmoqda va oxirgi ko'rsatkich 6.10 ni tashkil etdi. Moliyaviy barqarorlik stomatologik uskunalarining global savdosi va raqamli modellashtirish bo'yicha ekspertlarning saqlanib qolishi bilan ta'minlanmoqda. Ushbu grafik aksiyalar hajmining bozor tomonidan yutilish sur'atini biznesning haqiqiy daromadliligiga nisbatan aniq ko'rsatadi.

Envista (NVST) - P/E multiplikatori 04.07.2022dan 17.11.2026gacha

Envista Holdings kompaniyasining tahliliy kesimlari

Kompaniyaning umumiy tahlili:Envista Holdings Corporation, NVST
Envista Holdings tovar namunasi

Investorlar biznesning bozor qiymati va uning foyda keltirish qobiliyati nisbatini tahlil qilish orqali aktivlarning qiymati pasayishi xavfini baholaydilar. Envista Holdings (NVST) kompaniyasining rivojlanayotgan stomatologiya bozorlariga kengayganini hisobga olgan holda, kompaniyaning nisbiy P/E koeffitsiyenti bozor kapitalizatsiyasini real pul oqimlariga aylantirish samaradorligini ko'rsatadi, bunda koeffitsiyentning haddan tashqari o'sishi aktivning haddan ortiq sotib olinganligidan dalolat bersa, past baholangan koeffitsiyentlar resurslardan yetarlicha foydalanilmaganligi ehtimolini anglatadi.

Raqobatdosh kompaniyalar tahlili

P/E multiplikatori Intuitive Surgical, Inc.|Narx-foyda koeffitsiyenti DHR (Danaher Corp)|BDX (Becton, Dickinson and Company) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori STE (steris.com)|Biznesning o‘zini qoplash muddati westpharma.com (WST)|BAX - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Masimo Corp MASI|Stevanato Group S.p.A. (STVN) - Narxning foydaga nisbati|TFX - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati merit.com|ICU Medical (ICUI) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti XRAY (DENTSPLY SIRONA Inc.)|Bozor narxining sof foydaga nisbati LMAT|Narxning foydaga nisbati AtriCure Corp ATRC|Kompaniya qiymatining sof foydaga nisbati STAA|NAGE: Narx-foyda koeffitsiyenti|ZIMV - P/E multiplikatori|AngioDynamics Inc (ANGO) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Cerus|TKNO (teknova.com) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Monogram Orthopedics Inc. MGRM|Narxning foydaga nisbati Sharps Tech (STSS)|InfuSystem Inc - Narx-foyda multiplikatori|Utah Medical Products - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati KRMD (KORU Medical Systems)|NYXH - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Microbot Medical, Inc MBOT|Pro-Dex Corp (PDEX) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati ZTEK (Zentek Ltd.)|Narxning foydaga nisbati Elutia|Milestone Scientific Inc (MLSS) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti NXGL (NEXGEL, Inc.)|RVP (Retractable Technologies, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Harvard Bioscience, Inc. - Narx-foyda koeffitsiyenti|P/E multiplikatori femasys.com FEMY|MHUA: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati predictive-oncology.com POAI|Callan JMB Inc (CJMB) - Narxning foydaga nisbati|Narx-foyda multiplikatori ATRI|NURO (NeuroMetrix Inc) - P/E multiplikatori